These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 33300954

  • 1. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment.
    Deutsch BC, Collopy C, Kallogjeri D, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2021 Feb 01; 147(2):182-189. PubMed ID: 33300954
    [Abstract] [Full Text] [Related]

  • 2. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer.
    Schuette A, Lander DP, Kallogjeri D, Collopy C, Goddu S, Wildes TM, Daly M, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2020 Feb 01; 146(2):106-112. PubMed ID: 31750863
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):779-88. PubMed ID: 18707819
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V, Meyer F, Guitton MJ, Bussières R, Philippon D, Bairati I, Leclerc M, Côté M.
    J Otolaryngol Head Neck Surg; 2019 Jan 16; 48(1):4. PubMed ID: 30651130
    [Abstract] [Full Text] [Related]

  • 11. A new grading system for ototoxicity in adults.
    Theunissen EA, Dreschler WA, Latenstein MN, Rasch CR, van der Baan S, de Boer JP, Balm AJ, Zuur CL.
    Ann Otol Rhinol Laryngol; 2014 Oct 16; 123(10):711-8. PubMed ID: 24820112
    [Abstract] [Full Text] [Related]

  • 12. The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy.
    Duinkerken CW, Chiodo S, Hueniken K, Hauptmann M, Jóźwiak K, Cheng D, Hope A, Liu G, Zuur CL.
    Cancer Med; 2024 Aug 16; 13(16):e7465. PubMed ID: 39159054
    [Abstract] [Full Text] [Related]

  • 13. The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer.
    Caballero M, Mackers P, Reig O, Buxo E, Navarrete P, Blanch JL, Grau JJ.
    Oncology; 2017 Aug 16; 93(2):75-82. PubMed ID: 28511189
    [Abstract] [Full Text] [Related]

  • 14. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N, Kaushal D, Patro SK, Pareek P, Dixit A, Soni K, Prakasan Nair N, Choudhury B, Goyal A.
    Acta Otolaryngol; 2021 Sep 16; 141(9):885-893. PubMed ID: 34486907
    [Abstract] [Full Text] [Related]

  • 15. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
    Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1393-402. PubMed ID: 15817342
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
    Zuur CL, Simis YJ, Lamers EA, Hart AA, Dreschler WA, Balm AJ, Rasch CR.
    Int J Radiat Oncol Biol Phys; 2009 Jun 01; 74(2):490-6. PubMed ID: 19135315
    [Abstract] [Full Text] [Related]

  • 17. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
    Crabb SJ, Martin K, Abab J, Ratcliffe I, Thornton R, Lineton B, Ellis M, Moody R, Stanton L, Galanopoulou A, Maishman T, Geldart T, Bayne M, Davies J, Lamb C, Popat S, Joffe JK, Nutting C, Chester J, Hartley A, Thomas G, Ottensmeier C, Huddart R, King E.
    Eur J Cancer; 2017 Dec 01; 87():75-83. PubMed ID: 29128692
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Audiological profile of patients treated for childhood cancer.
    Liberman PH, Goffi-Gomez MV, Schultz C, Novaes PE, Lopes LF.
    Braz J Otorhinolaryngol; 2016 Dec 01; 82(6):623-629. PubMed ID: 27156673
    [Abstract] [Full Text] [Related]

  • 20. Long-term hearing loss after chemoradiation in patients with head and neck cancer.
    Theunissen EA, Zuur CL, Bosma SC, Lopez-Yurda M, Hauptmann M, van der Baan S, de Boer JP, van der Molen L, Rasch CR, Dreschler WA, Balm AJ.
    Laryngoscope; 2014 Dec 01; 124(12):2720-5. PubMed ID: 24964759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.